David Lucchino, chief executive officer of Frequency Therapeutics, is expected to be named the next chairman of MassBio next month.
Source: BioSpace
David Lucchino, chief executive officer of Frequency Therapeutics, is expected to be named the next chairman of MassBio next month.
Source: BioSpace